Prospective Memory in Parkinson's Disease

Completed

• Conditions: Parkinson's Disease; Memory; Prospective Memory

• Registration Number: NCT00913640
• Lead Sponsor: Washington University School of Medicine

Brief Summary

The investigators tested whether prospective memory is impaired in individuals with Parkinson's Disease compared to controls using reliable and validated experimental measures. Also, the investigators assessed the impact of Parkinson's medication on prospective memory performance in PD to better estimate prospective memory function in PD patients' everyday (chronically treated) life.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-06-01
• Study First Submitted QC: 2009-06-03
• Study First Posted: 2009-06-04
• Study Start: 2009-11-18
• Primary Completion: 2010-08-27
• Study Completion: 2010-08-27
• Status Verified: 2022-05
• Last Update Submitted: 2022-05-02
• Last Update Posted: 2022-05-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 52

Inclusion Criteria

• PD Group:

  • Clinically definite PD
  • 40-70 years old
  • Hoehn and Yahr stage I,II,III
  • Currently treated with Levodopa/carbidopa

• Control Group:

  • 40-70 years old
  • Spouses of PD Group preferred

Exclusion Criteria

• PD Group and Control Group:

  • Significant neurological problems
  • Significant current psychiatric diagnoses
  • Mini Mental Status Exam score < 24 (MMSE)
  • Any significant abnormality on brain imaging
  • MPTP exposure
  • Control Participants met the same exclusion criteria described above as well as a biological family history of PD

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Virtual Week	One session at baseline.	Prospective Memory Task; Score range is 0-100%, with higher scores being better performance.

Trial Locations

Locations (1)

Washington University School of Medicine; 🇺🇸 Saint Louis, Missouri, United States